The risk or severity of adverse effects can be increased when Cerivastatin is combined with Atorvastatin. Raltegravir may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Metergoline is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Itraconazole. The serum concentration of Metoprolol can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Desipramine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Z-Val-Ala-Asp fluoromethyl ketone. The risk or severity of adverse effects can be increased when Ezetimibe is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Insulin Pork. The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Fosamprenavir. The serum concentration of Atorvastatin can be increased when it is combined with Tipranavir. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Ketoconazole. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Spironolactone. The risk or severity of adverse effects can be increased when Niludipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Cyproterone acetate. The risk or severity of adverse effects can be increased when Pinaverium is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ixazomib. The risk or severity of adverse effects can be increased when Methylergometrine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Candoxatril. The risk or severity of adverse effects can be increased when Alprazolam is combined with Atorvastatin. Azithromycin may increase the myopathic rhabdomyolysis activities of Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Delanzomib. The serum concentration of Atorvastatin can be increased when it is combined with Imidapril. The risk or severity of adverse effects can be increased when Ambroxol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ciprofloxacin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Flunarizine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tadalafil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Solithromycin is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Rifampicin. The risk or severity of adverse effects can be increased when Fluoxetine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Glyburide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Loratadine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Simeprevir. The risk or severity of adverse effects can be increased when Ethanol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clotiazepam is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clindamycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Miconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Tocilizumab. The serum concentration of Atorvastatin can be decreased when it is combined with Bexarotene. The serum concentration of Aliskiren can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bortezomib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin. The serum concentration of Atorvastatin can be increased when it is combined with Posaconazole. The risk or severity of adverse effects can be increased when Ziprasidone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Barnidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Butoconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Atorvastatin. The serum concentration of Vincristine can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tranilast is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Oxiconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Fluvastatin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Terconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sulconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Telaprevir. The risk or severity of adverse effects can be increased when Buprenorphine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Caffeine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Trandolapril. The serum concentration of Thioridazine can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine. The serum concentration of Atorvastatin can be decreased when it is combined with Deferasirox. The risk or severity of adverse effects can be increased when Salbutamol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Methadone is combined with Atorvastatin. The serum concentration of Amodiaquine can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Paclitaxel is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Levosalbutamol is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Temocapril. Atorvastatin may increase the anticoagulant activities of Dicoumarol. The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tetrahydropalmatine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Methimazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tramadol is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glisoxepide. Colchicine may increase the myopathic rhabdomyolysis activities of Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Linagliptin. The risk or severity of adverse effects can be increased when Oxybutynin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glipizide. The risk or severity of adverse effects can be increased when Pazopanib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Prednisolone is combined with Atorvastatin. The serum concentration of Ibrutinib can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Darodipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Dronedarone. The serum concentration of Atorvastatin can be increased when it is combined with Spirapril. The risk or severity of adverse effects can be increased when Luliconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cilnidipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ticagrelor. The serum concentration of Atorvastatin can be increased when it is combined with Prinomastat. The serum concentration of Atorvastatin can be increased when it is combined with Ombitasvir. The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Rivaroxaban. The risk or severity of adverse effects can be increased when Azelnidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Pimozide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Econazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Paramethasone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Alpha-1-proteinase inhibitor. The risk or severity of adverse effects can be increased when Gabapentin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Prenylamine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Elafin. The serum concentration of Atorvastatin can be decreased when it is combined with Magnesium oxide. The serum concentration of Atorvastatin can be increased when it is combined with Asunaprevir. The risk or severity of adverse effects can be increased when Isavuconazonium is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Boceprevir. The risk or severity of adverse effects can be increased when Iloperidone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lomustine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Zafirlukast is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Rescinnamine. The metabolism of Atorvastatin can be increased when combined with Phenobarbital. The risk or severity of adverse effects can be increased when Clevidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Zucapsaicin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Oxymetholone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Batimastat. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Cimetidine. The risk or severity of adverse effects can be increased when Niguldipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Daclatasvir. The risk or severity of adverse effects can be increased when Venlafaxine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ceritinib is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Fluindione. The serum concentration of Atorvastatin can be increased when it is combined with Benazepril. The risk or severity of adverse effects can be increased when Pergolide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cinnarizine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Haloperidol is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Faldaprevir. The serum concentration of Atorvastatin can be increased when it is combined with Sitagliptin. The serum concentration of Atorvastatin can be increased when it is combined with S-3304. The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Efonidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Hydralazine is combined with Atorvastatin.